The Markets Now: Stocks Pare Losses After Europe, Home Sales Send Stocks Lower

By Christopher Witrak  MAR 27, 2013 2:20 PM

Plus, Gilead Sciences will likely receive approval for its HIV medication.

 


No positions in stocks mentioned.